Cambridge, UK-based Inivata Ltd has appointed Timothy Shannon as chief financial officer. He will be responsible for the company’s global business operations from Research Triangle Park, North Carolina, US. Founded in 2014, Inivata is developing diagnostics for cancer by analysing circulating tumour DNA.
Mr Shannon previously worked for Baxano Surgical, Inc, a former medical device company that ceased trading in 2015, and for Talecris Biotherapeutics Inc. At Talecris, he managed the company’s initial public offering of shares in 2009. Talecris was acquired by Grifols SA of Spain in June 2011.
Copyright 2016 Evernow Publishing Ltd